secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAGENICS INC (OGEN)
CIK:        0001174940
Form:       8-K
Filed at:   2022-12-16T23:59:59+00:00
Accession:  0001493152-22-035730
Event type: leadership
Sentiment:  negative
Materiality: 0.70
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oragenics CFO resigns; CEO assumes interim role; shareholders reject authorized share increase
--------------------------------------------------------------------------------

- Michael Sullivan resigned as CFO, Secretary, and Treasurer effective December 14, 2022.
- CEO Kimberly Murphy appointed as Interim CFO, Secretary, and Treasurer effective December 15, 2022.
- Sullivan will remain as consultant from December 15, 2022 through January 31, 2023 for transition.
- At 2021 Annual Meeting on December 16, 2022, all five director nominees were re-elected.
- Proposal to increase authorized common shares from 250M to 350M failed; 34.8M for, 9.0M against, 0.8M abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1174940/000149315222035730/0001493152-22-035730-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1174940/000149315222035730/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-035730

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer